Healthcare Leadership & Management & AI EXpert

Medicare STAR Rating Changes 2027

CMS-4212-P: Contract Year 2027 Policy Changes

CMS-4212-P Insights

Contract Year 2027 Proposed Rule

The Era of Equity & Precision

CMS is proposing significant technical changes to the Medicare Advantage (Part C) and Part D programs. The CY 2027 rule doubles down on the Health Equity Index (HEI), refines the Star Ratings methodology, and tightens Utilization Management controls.

Impact Year

2027

Full implementation of new cut-points

Est. Cost Impact

High

Due to rebate calculation changes

Focus Shift

Social

Social Risk Factors (SRF) weighting

Star Rating Evolution

The most critical component of CMS-4212-P is the recalibration of the Star Rating system. CMS proposes shifting weight away from purely administrative process measures and heavily weighting Outcomes and Patient Experience, underpinned by the new Health Equity Index.

Key Takeaway

Plans ignoring Social Determinants of Health (SDOH) will see rating degradation. The “Hold Harmless” provisions are being tightened.

Weighting Shift: Current vs. Proposed 2027

Comparison of relative impact on final score Calculation

Operational Burden Estimate

Estimated increase in administrative hours per 1,000 members to comply with new reporting and appeal requirements.

QBP Revenue at Risk

Projected distribution of plans losing 4+ Star status (and Quality Bonus Payments) under new cut-points.

Detailed Proposed Changes

A breakdown of specific regulatory adjustments found in 42 CFR Parts 422 and 423.

Domain Proposed Change Impact Analysis Readiness
Star Ratings Health Equity Index (HEI) fully integrated into calculation. Reward factor replaced. High Impact
Plans with low low-income subsidy (LIS) populations may see score drops. 		Collect SDOH data now.
Utilization Mgmt Prior Auth Alignment. Decision times shortened to match Fee-for-Service standards. Medium Impact
Requires IT staffing increase for faster processing. 		Audit UM workflows.
Marketing “Predatory” Definition expanded. Strict limits on sharing beneficiary data with TPMOs. Medium Impact
Sales channel disruption. 		Review TPMO contracts.
Network Behavioral Health adequacy standards tightened. Wait time maximums proposed. High Impact
Contracting difficulty in rural areas. 		Expand Telehealth network.
Part D Formulary Changes. Restrictions on mid-year tier changes. MTM eligibility expanded. Low Impact
Mainly affects Pharmacy Benefit Managers (PBMs). 		Update P&T protocols.

Path to Readiness: The 2026-2027 Timeline

1

Q1 2026

Submit Comments & Analyze Final Rule

Policy Review
2

Q3 2026

Data Simulation & Network Gap Analysis

IT & Network
3

Q4 2026

Mock Audits: UM & Grievances

Compliance
4

Jan 2027

Go-Live: New Benefit Year

Operations

Generated for CMS Regulatory Analysis.

Based on CMS-4212-P Proposed Rule. Data is illustrative for planning purposes.

CMS-4212-P Impact Dashboard

Contract Year 2027 Proposed Rule
Status Proposed
Deadline Jan 26, 2026
Primary Focus
Health Equity
New Index (HEI)
Financial Impact
High Risk
QBP Cut-point Volatility
Key Dept
Compliance/IT
Reporting Burden
Effective Date
Jan 1, 2027
Full Implementation

Operational Burden

Readiness Gaps

Proposed Change Matrix

Change Domain Proposal Summary Impact Strategic Action

The HEI Revolution

The Health Equity Index (HEI) fully replaces the Reward Factor. Plans failing to collect SDOH data or improve outcomes for LIS/DE populations face immediate mathematical disadvantages.

Risk Alert: “Hold Harmless” provisions are tightening. Administrative excellence can no longer mask poor equity performance.

Weighting Shift Simulation (2025 vs 2027)

Compliance Roadmap

Nov 2025: Proposed Rule Released

Analysis begins. Identify gap areas in SDOH data collection.

Jan 26, 2026: Comment Deadline

Critical: Submit comments on TPMO restrictions and Network Adequacy calculations.

April 2026: Final Rule

Final Rate Announcement. Confirm cut-points for 2027.

Jan 1, 2027: Go-Live

New Star Rating methodology and Part D rules in full effect.